Found 3,907 presentations matching your search
Introduction, IND, NDA, ANDA, IMPD, IB.
NON CLINICAL DRUG DEVELOPMENT
Bpharmacy 8 semester pharmaceutical Regulatory science bp804T Unit I New Drug Discovery and develo...
Non Clinical Drug Development: Global submission of IND, NDA, ANDA.
Contents Guidelines for Preparation of Documentation Clinical Study Reports Clinical Trial Monitorin...
Contrast agents play a crucial role in advancing research and medicine by enhancing the clarity and ...
What You Will Learn The FDA’s CBER will begin requiring electronic submissions of nonclinical dat...
B. Pharm. Final Year, Sem-VIII, BP804 ET: PHARMACEUTICAL REGULATORY SCIENCE (Theory). Unit-I Chapter...
ICH Guidelines were created by The International Council for Harmonization of Technical Requirements...
includes the details of new drug development and different phases of clinical trials
Regulatory Requirements For New Drug Approval. This topic is from Industrial Pharmacy-II, B.Pharm Fi...
This ppt focuses on the efficacy and multidisciplinary guidelines of ICH guidelines.
screening of pre clincal models
ICH Guidelines of Quality, Safety, Efficacy and Multidisciplinary guidelines that implemented by Int...
A NEW TRY WITH SOME INFORMATION
Presentation on Investigational New Drug (IND) enabling studies
This presentation covers the ICH guidelines coding no in details.
IND- Investigational New Drug
ich guidelines for clinical trials, general principles, scientific approach .
Importance of academia in ensuring access to safe and effective medicines
Clinical trials and new drug development
toxicokinetics evaluation in preclinical studies and saturation kinetics : anmolkanda
Toxicokinetic evaluation in preclinical studies. m.pharm 2nd sem pharmacology topic.
